These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12968557)

  • 1. Clinical positron emission tomography imaging--current applications.
    Goh AS; Ng DC
    Ann Acad Med Singap; 2003 Jul; 32(4):507-17. PubMed ID: 12968557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-modality PET/CT tomography for clinical oncology.
    Beyer T; Townsend DW; Blodgett TM
    Q J Nucl Med; 2002 Mar; 46(1):24-34. PubMed ID: 12072843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does positron emission tomography offer oncology?
    Anderson H; Price P
    Eur J Cancer; 2000 Oct; 36(16):2028-35. PubMed ID: 11044638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined imaging modalities: PET/CT and SPECT/CT.
    Maurer AH
    Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic principles of positron emission tomography in oncology: quantitation and whole body techniques.
    Hoh CK; Dahlbom M; Hawkins RA; Glaspy JA; Yao WJ; Lee SJ; Maddahi J; Phelps ME
    Wien Klin Wochenschr; 1994; 106(15):496-504. PubMed ID: 7941598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
    Cook GJ; Wegner EA; Fogelman I
    Semin Nucl Med; 2004 Apr; 34(2):122-33. PubMed ID: 15031812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography: diagnostic imaging on a molecular level].
    Allemann K; Wyss M; Wergin M; Bley CR; Ametamay S; Bruehlmeier M; Kaser-Hotz B
    Schweiz Arch Tierheilkd; 2004 Aug; 146(8):359-64. PubMed ID: 15379168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of FDG-PET in oncology.
    Czernin J
    Acta Med Austriaca; 2002; 29(5):162-70. PubMed ID: 12506767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography as a diagnostic tool in oncology.
    Schiepers C; Hoh CK
    Eur Radiol; 1998; 8(8):1481-94. PubMed ID: 9853241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in tumor diagnosis and treatment follow-up.
    Bergström M
    Acta Oncol; 1993; 32(2):183-8. PubMed ID: 8323760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamentals of positron emission tomography and applications in preclinical drug development.
    Cherry SR
    J Clin Pharmacol; 2001 May; 41(5):482-91. PubMed ID: 11361044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of positron emission tomography (PET) in oncology.
    Weber WA; Avril N; Schwaiger M
    Strahlenther Onkol; 1999 Aug; 175(8):356-73. PubMed ID: 10481766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography: establishing priorities for health technology assessment.
    Robert G; Milne R
    Health Technol Assess; 1999; 3(16):1-54. PubMed ID: 10632626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.